(NASDAQ:CHR),(NASDAQ:GSMGW), Class A Ordinary Shares Will Begin Trading on a Post-Consolidation Adjusted Basis onDecember 23, 2025 BEIJING, Dec. 19, 2025 (GLOBE NEWSWIRE) — Cheer Holding, Inc. (NASDAQ: CHR) (“Cheer Holding,” “we” or the “Company”), a leading provider of next-generation mobile internet infrastructure and platform services, today announced that it intends to effect a share consolidation […]
(NasdaqGM:CSTL), FRIENDSWOOD, Texas, Dec. 19, 2025 (GLOBE NEWSWIRE) — Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that on Dec. 15, 2025, the Compensation Committee of its Board of Directors granted restricted stock units (RSUs) to 83 employees covering an aggregate of 139,494 shares of
(NASDAQ:EVAX), MSD declines to exercise option for EVX-B2 development Evaxion is now able to out-license EVX-B2 to another partner Evaxion maintains its strong belief in EVX-B2, which has shown to be protective against Gonorrhea in preclinical studies There is no impact on Evaxion's cash runway which extends to the second half of 2027 COPENHAGEN, Denmark,
SAN SALVADOR, El Salvador, Dec. 19, 2025 (GLOBE NEWSWIRE) — Bitget Wallet, the leading everyday finance app, has added support for Tether Gold (XAUâ‚®), enabling users to access tokenized gold onchain within a self-custodial wallet. The integration reflects growing demand for real-world assets on blockchain networks, as investors increasingly seek exposure to established stores of
Psyence BioMed Announces Approval for Use of PsyLabs' Psilocybin Product in Phase IIb Clinical Trial With approximately $9.5 million in cash reserves and no debt, the Company is ready to leverage strengthened vertical integration as clinical-grade psilocybin moves into Phase IIb trials GlobeNewswire December 19, 2025 NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) — Psyence
OKYO Pharma to Ring the Opening Bell at Nasdaq GlobeNewswire December 19, 2025 LONDON and NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company which is developing urcosimod to treat neuropathic corneal pain (NCP), an ocular condition associated with chronic and often severe nerve-related pain but without
Safe & Green Holdings Completes Strategic Acquisition of Giant Containers GlobeNewswire December 19, 2025 Conroe, Texas, Dec. 19, 2025 (GLOBE NEWSWIRE) — CONROE, Texas, Dec 19, 2025 (GLOBE NEWSWIRE) — via IBN – Safe & Green Holdings Corp. (NASDAQ: SGBX) (“Safe & Green” or the “Company”), announced that it has successfully closed the acquisition of
NFI Group Amends Agreement with Coliseum Capital Management GlobeNewswire December 19, 2025 Provides Coliseum flexibility to increase its ownership up to 25% of NFI's outstanding shares Reflects long-term support and confidence of NFI's largest shareholder WINNIPEG. Manitoba, Dec. 19, 2025 (GLOBE NEWSWIRE) — (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (“NFI” or the
Malibu Boats Inc. Expands Share Repurchase Program to $70 Million Capital allocation strategy aims to combine investing in core business and returning excess capital to shareholders GlobeNewswire December 19, 2025 LOUDON, Tenn., Dec. 19, 2025 (GLOBE NEWSWIRE) — Malibu Boats, Inc. (Nasdaq: MBUU), a U.S. designer and manufacturer of category-leading salt and freshwater recreational powerboat
Chicago Atlantic Real Estate Finance Declares Common Stock Dividend of $0.47 for the Fourth Quarter of 2025 GlobeNewswire December 19, 2025 CHICAGO, Dec. 19, 2025 (GLOBE NEWSWIRE) — Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI), a commercial mortgage real estate investment trust, announced that its board of directors has declared a regular quarterly cash